USFDA approves Libtayo for skin cancer treatment

The US Food and Drug Administration (FDA) has approved Libtayo to be used for the treatment of patients having two of the most common skin cancers in the

The post USFDA approves Libtayo for skin cancer treatment appeared first on Pharmaceutical Business review.

This is not a CAPTIS article. Originally, it was published here.